menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Grifols, Inpeco Partner to Modernize Lab Operations

    CONTRACTPHARMA

    Grifols Develops Analysis Tech To Detect Early Parkinson’s Signs

    GLOBENEWSWIRE

    Grifols Awarded $21M Michael J. Fox Foundation Grant

    CONTRACTPHARMA

    Grifols shares tumble after Brookfield drops takeover plan

    REUTERS

    Court opens investigation into Gotham City`s attack on Grifols

    REUTERS

    Brookfield mulls $7.4 bln bid for Spain`s Grifols, El says

    REUTERS

    Grifols Receives FDA Approval for Pediatric Bleeding Treatment

    GLOBENEWSWIRE

    Grifols Partners With BARDA For Ocular Immunoglobulin Testing

    GLOBENEWSWIRE

    GigaGen garners up to $135M BARDA bucks to beat botulism

    FIERCE BIOTECH

    Grifols Plans $402M Investment In New Industrial Centre

    REUTERS

    Grifols minority shareholders team up to ask for a board seat

    REUTERS

    Grifols Receives Expanded XEMBIFY® Label In U.S. For IG Portfolio

    GLOBENEWSWIRE

    Grifols Gets $6B Takeover Offer from Founding Family, Brookfield to Go Private

    BIOSPACE

    Spanish drugmaker Grifols appoints new finance chief as shake-up continues

    REUTERS

    Unit of Grifols shareholder Scranton reaches debt refinancing deal

    REUTERS

    Grifols` Biotest Projects $1B US Sales Of Yimmugo Over 7 Years

    GLOBENEWSWIRE

    Grifols Completes Sale Of 20% Stake In SRAAS And Forms Alliance With Haier Group

    GLOBENEWSWIRE

    Grifols Receives FDA Approval For Yimmugo® To Treat Primary Immunodeficiencies

    GLOBENEWSWIRE

    Grifols Partnership has received four CDMO Leadership Awards in 2024

    PRESS RELEASE

    Inc Medical Industries Partnership with Grifols for Enhanced Medication Safety

    PR NEWSWIRE

    Grifols Procleix ArboPlex Assay® Receives CE Mark

    GLOBENEWSWIRE

    Shares in Spanish drugmaker Grifols tumble on Fitch, S&P downgrades

    REUTERS

    Grifols says due diligence done, Shanghai RAAS stake sale to go ahead

    REUTERS

    Spanish supervisor analysing new information from Grifols

    REUTERS

    Grifols appoints new CEO Nacho Abia to the board

    REUTERS

    Grifols preps blood clot treatment approval push after ph. 3 win

    FIERCE PHARMA

    Spain`s Grifols hires new CEO weeks after damaging short-seller report

    REUTERS

    Grifols files lawsuit against hedge fund for making `false and misleading statements`

    FIERCE PHARMA

    Spain`s Grifols sues Gotham City fund, JV over damaging report

    REUTERS

    ECB sounds out lenders on exposure to Spanish drugmaker Grifols - sources

    REUTERS

    Grifols says Haier Group still OK to buy stake in Shanghai RAAS

    REUTERS

    Grifols shares suffer worst week on record after short-seller report

    REUTERS

    Spain`s Grifols to sue short-seller over critical report, shares jump

    REUTERS

    Grifols accused of manipulating finances by short seller Gotham City

    ENDPTS

    Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%

    GLOBENEWSWIRE

    Grifols shares soar after 2023 profit outlook upgrade

    REUTERS

    Araclon vaccine appears to slow Alzheimer`s in phase 2 analysis

    FIERCE BIOTECH

    Araclon Presents Positive Final Results from Phase 2 Clinical Study of ABvac40

    GLOBENEWSWIRE

    AIS Healthcare’s Infusion Care Announces Joint Study with Grifols

    BUSINESSWIRE

    Grifols Accelerates Healthcare Innovation with Google Cloud™s AI and Analytics

    GLOBENEWSWIRE

    Grifols Partners with Google Cloud to Advance Drug Development

    CONTRACT PHARMA

    Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY

    GLOBENEWSWIRE

    Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein

    GLOBENEWSWIRE

    Grifols Meets Enrollment Target in PIII of Two Dose Regimens of Prolastin®-C

    GLOBENEWSWIRE

    Astellas president jumps to a new Frontier; Grifols chairman named CEO

    ENDPTS

    Grifols Launches AlphaID At Home, Enabling U.S. Consumers to Self-Screen

    GLOBENEWSWIRE

    Grifols lifts 2023 margin outlook as revenue rises

    REUTERS

    Spain`s Grifols names current chairman as CEO, ending family leadership

    REUTERS

    Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023

    PR NEWSWIRE

    Selagine Enters into a Collaborative Agreement with Grifols

    PR NEWSWIRE

    Grifols` shares tank 10% as 2023 outlook disappoints

    REUTERS

    Grifols is the latest drugmaker to succumb to the layoff trend

    FIERCE PHARMA

    Grifols receives FDA clearance for AlphaID At Home

    PRNEWSWIRE

    Grifols opens plant, snags NICE nod for Tavlesse

    FIERCEPHARMA

    Grifols in 15-year deal with Canada for plasma-based medicines

    EXPRESS PHARMA

    Victor Grifols Roura decides to retire as Chairperson

    GRIFOLS

    Grifols appoints executive chairman as seeks to speed recovery

    REUTERS

    Grifols enters into agreement with Canadian Blood Services

    PRNEWSWIRE

    Grifols in 15-year deal with Canada for plasma-based medicines

    REUTERS

    Grifols highlights an increase in plasma and underscores innovation

    PRESS RELEASE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.